In Vitro Analysis of Human Urine With the CloudCath Device

NCT04950582 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-09-21

No results posted yet for this study

Summary

This is a multi-center feasibility study to assess the in vitro function of the CloudCath Device that is being developed to derive clinically-relevant information from the optical characteristics of urine.

Conditions

Interventions

DIAGNOSTIC_TEST

Spectral characteristics assessment

Urine sample analysis for evidence of urinary tract infection

Sponsors & Collaborators

  • CloudCath

    lead INDUSTRY

Principal Investigators

  • Ben Briggs, MD, PhD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2024-06-15
Completion
2024-06-15
FDA Device
Yes

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04950582 on ClinicalTrials.gov